An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new Covid-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines.

Public Citizen sent a letter to Pfizer Chief Executive Albert Bourla on Monday, asking the drugmaker to set aside at least two-thirds of its supply this year for developing countries at a reasonable price.